Denise Lau

Denise Lau is a Senior Computational Biologist at Adaptive Biotechnologies Corp., specializing in the development of computational tools for target discovery and validation in autoimmune disease and oncology, collaborating closely with bench scientists on advanced technologies. Prior experience includes serving as Director of Computational Immunology at Tempus, Inc., where Denise led a team in biomarker development and integrated clinical data with sequencing results to predict therapeutic outcomes. Denise's background also features a Senior Computational Biologist role at Tempus, where the design and deployment of the computational immunology pipeline were spearheaded. An academic foundation includes a PhD in Immunology from the University of Chicago and a BA in Molecular and Cellular Biology from the University of California, Berkeley.